The age a woman experiences natural menopause is associated with her risk of developing type 2 diabetes.
The age a woman experiences natural menopause is associated with her risk of developing type 2 diabetes.
Previous research has demonstrated a link between early menopause and an increased risk of cardiovascular disease (CVD). During menopause, a woman experiences weight gain, decreased estrogen levels, increased visceral fat, and an impaired glucose metabolism. These adverse effects may contribute to a greater risk of type 2 diabetes, which leads to the increased risk of CVD.
A recent study published by Diabetologia evaluated 3639 postmenopausal women from the Rotterdam Study, who self-reported their age at natural menopause. The participants were then divided into categories of premature (<40 years old), early (40-44 years old), normal (45-55 years old), and late menopause (>55 years old). Type 2 diabetes data was collected from medical records of blood glucose measurements at clinical visits.
Of the 3639 postmenopausal women included in the study, 348 developed type 2 diabetes over the median follow-up of 9.2 years. When comparing the association among ages of natural menopause, women with late menopause had statistically significant lower risk of developing type 2 diabetes. For premature menopause, type 2 diabetes was 3.65 (hazard ratio) times more likely, 2.36 times more likely for early menopause, and 1.62 times for likely for normal menopause, when compared with women who experience late menopause.
The study suggested that early natural menopause may be a marker of premature aging and related to longevity. Therefore, age at natural menopause may be associated with DNA damage repair, which is linked to type 2 diabetes risk.
“Hence, early menopause might be a consequence of accelerated ageing of the soma and might therefore be a very good predictor of general health in later life, including type 2 diabetes risk,” wrote the researchers. “However, when we adjusted for shared genetic factors, our results did not change.”
Despite the lifestyle factors, like smoking and alcohol consumption, that are often linked to the age of menopause, the study did not find an association or influence between the factors and the results. Therefore, the connection between type 2 diabetes development and natural menopause age remains unclear.
“Early onset of natural menopause is an independent marker of type 2 diabetes risk in postmenopausal women,” concluded the study. “Future studies are needed to examine the mechanisms behind this association and explore whether the timing of natural menopause can add value to diabetes prediction and prevention.”
The Joint Commission is launching the Rural Health Clinic Accreditation Program to standardize staff training and patient care practices at rural health clinics nationwide; the American Cancer Society recently launched the largest-ever study of cancer risk and outcomes in Black women; the HHS COVID-19 vaccination campaign saved $732 billion by preventing illness and related costs.
Read More
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More